27 April 2016
Mercia Fund Management, a leading investment business in UK innovation and a wholly-owned subsidiary of Mercia Technologies PLC, is collaborating with the WMAHSN to help build and support healthcare start-ups across the West Midlands.
The SME Innovation Fund is led by Mercia’s Head of Life Sciences, Peter Dines. It aims to grow spin-outs to improve healthcare services across the NHS, particularly those in line with the WMAHSN’s core strategic priorities; advanced diagnostics, genomics and precision medicine; mental health: recovery, crisis and prevention; long-term conditions; and wellness and the prevention of illness.
The WMAHSN brings together investment, energy and expertise from across the health science community. In collaborating with Mercia, it will help to provide repayable grants of up to £50,000 to at least ten new innovations each year. In so doing, the fund will support innovations that have the potential to deliver a high impact for society, grow the reputation of healthcare delivery within the West Midlands, both in the UK and abroad, and support the spread and adoption of patient-focused innovation across the region.
The SME Innovation Fund is now available to support the challenges identified across the WMAHSN’s enabling themes and clinical priorities.
The SME Innovation Fund was launched on 27 April 2016 in order to support the challenges identified across the WMAHSN’s priorities. For more information on how to invest in the fund, or to apply for funding, please email Peter Dines at email@example.com or Lucy Chatwin at firstname.lastname@example.org.
t: 0121 371 8061